The NIST Biomanufacturing Program draws from a broad array of unique, interdisciplinary expertise, resources, and facilities including
- biophysical characterization of biotherapeutics including colloidal and rheological measurements
- state-of-the-art mass spectrometry, NMR, and cryo-electron microscopy capabilities for characterizing biotherapeutics
- world-class neutron and X-ray scattering facilities to determine biotherapeutic stability and structure
We work closely with stakeholders (biopharmaceutical industry, FDA, and equipment vendors) to identify key measurement problems. NIST holds an annual Biopharmaceutical Measurement Roundtable consisting of members of the industry for feedback on the relevance of its research activities, and to learn of current and emerging measurement needs.
NIST is a trusted, impartial third party that promotes cross-industry collaboration and open data sharing.
- The NIST monoclonal antibody reference material (NISTmAb) was characterized by a NIST-led effort involving 100 scientists from industry, government, and academia. The results are documented in a three-volume book, State-of-the-Art and Emerging Technologies for Monoclonal Antibody Characterization.
- NIST has conducted interlaboratory measurement comparisons with participation from across the industry to benchmark new emerging technologies including NMR, multi-attribute method, and particle measurement systems.
Foundational measurement science on protein structure, cell biology, and emerging measurement technologies (scattering methods, NMR, HDX-MS, cryo-EM, optical methods) described in over 100 publications.
Engagement with industry through
- consortia (examples: National Institute for Innovation in Biopharmaceutical Manufacturing, Advanced Mammalian Biomanufacturing Innovation Center) and other industry organizations
- direct collaborations with industry scientists on NMR and mass spectrometry interlaboratory measurement comparisons
- cooperative research and development agreements with leading biopharmaceutical companies
Measurement standards and data: NIST monoclonal antibody and protein particle reference materials, glycan reference materials and data, cell culture for protein reference material development, and mass spectrometry reference data.